公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation | YAO-WEN KUO ; SHANG-GIN WU ; CHAO-CHI HO ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 73 | 67 | |
2008 | Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern | SHANG-GIN WU ; YIH-LEONG CHANG ; Hsu Y.-C.; Wu J.-Y.; CHIH-HSIN YANG ; CHONG-JEN YU ; Tsai M.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | Oncologist | 72 | 67 | |
2011 | Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations | SHANG-GIN WU ; CHIH-HSIN YANG ; CHONG-JEN YU ; JIH-HSIANG LEE ; Hsu Y.-C.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 41 | 35 | |
2010 | Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women | TZU-PIN LU ; Tsai, M.-H.; JANG-MING LEE ; Hsu, C.-P.; Chen, P.-C.; CHUNG-WU LIN ; JIN-YUAN SHIH ; PAN-CHYR YANG ; CHUHSING KATE HSIAO ; LIANG-CHUAN LAI ; ERIC YAO-YU CHUANG | Cancer Epidemiology Biomarkers and Prevention | 248 | 234 | |
2015 | Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan | Hsu K.-H.; CHAO-CHI HO ; Hsia T.-C.; Tseng J.-S.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Chang G.-C. | PLoS ONE | 98 | 92 | |
2019 | IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer | SHANG-GIN WU ; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU ; YIH-LEONG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH | Cancers | 15 | 12 | |
2015 | IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer | Liu Y.-N.; Chang T.-H.; Tsai M.-F.; SHANG-GIN WU ; TZU-HSIU TSAI ; Chen H.-Y.; SUNG-LIANG YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Oncotarget | 57 | 56 | |
2019 | The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer | YEN-TING LIN ; Liu Y.-N.; JIN-YUAN SHIH | Frontiers in Oncology | 10 | 8 | |
2019 | Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients | ZONG-HAN YAO ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; ZHONG-ZHE LIN ; CHIA-CHI LIN ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 27 | 24 | |
2011 | Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction | SHANG-GIN WU ; YIH-LEONG CHANG ; JOU-WEI LIN ; CHEN-TU WU ; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; CHONG-JEN YU ; JIN-YUAN SHIH | PloS one | 49 | 43 | |
2015 | Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer | TZU-TANG WEI ; Lin, Yu-Chin; Lin, Pei-Hua; JIN-YUAN SHIH ; Chou, Chia-Wei; Huang, Wei-Jan; Yang, Yu-Chih; Hsiao, Pei-Wen; CHING-CHOW CHEN | Oncotarget | 12 | 12 | |
2010 | Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; PAN-CHYR YANG | Lung Cancer | 19 | 18 | |
2008 | Leg pains, clubbing of digits and lung mass: What is your call? | Wu J.-Y.; JIN-YUAN SHIH | CMAJ | 3 | 3 | |
2023 | LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis | Chen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH | Journal of biomedical science | 2 | 0 | |
2022 | The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients | FEI-HSIU HSIAO ; ZHONG-ZHE LIN ; Huang F.-Y.; Lai Y.-M.; Chen Y.-T.; JIN-YUAN SHIH ; CHAO-CHI HO ; CHONG-JEN YU ; Hsieh C.-C. | Mindfulness | 1 | 1 | |
2024 | Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study | Chang, Gee-Chen; Chiu, Chao-Hua; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Chang, Ya-Hsuan; Hsu, Kuo-Hsuan; Wu, Yu-Chung; CHIH-YI CHEN ; Hsu, Hsian-He; Wu, Ming-Ting; Yang, Cheng-Ta; Chong, Inn-Wen; Lin, Yu-Ching; Hsia, Te-Chun; Lin, Meng-Chih; Su, Wu-Chou; Lin, Chih-Bin; Lee, Kang-Yun; Wei, Yu-Feng; Lan, Gong-Yau; Chan, Wing P; Wang, Kao-Lun; Wu, Mei-Han; Tsai, Hao-Hung; Chian, Chih-Feng; Lai, Ruay-Sheng; JIN-YUAN SHIH ; Wang, Chi-Liang; Hsu, Jui-Sheng; Chen, Kun-Chieh; Chen, Chun-Ku; Hsia, Jiun-Yi; Peng, Chung-Kan; Tang, En-Kuei; CHIA-LIN HSU ; Chou, Teh-Ying; Shen, Wei-Chih; Tsai, Ying-Huang; Tsai, Chun-Ming; Chen, Yuh-Min; Lee, Yu-Chin; Chen, Hsuan-Yu; SUNG-LIANG YU ; Chen, Chien-Jen; Wan, Yung-Liang; Hsiung, Chao Agnes; PAN-CHYR YANG | The Lancet. Respiratory medicine | 1 | | |
2017 | Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | ERJ open research | 33 | 0 | |
2008 | Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation | SHANG-GIN WU ; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 11 | 9 | |
2023 | Lung adenocarcinoma with neuroendocrine differentiation: Molecular markers testing and treatment outcomes | HAO-CHUN CHANG ; KUAN-YU CHEN ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
1998 | Lung cancer in pregnancy: Report of two cases | KUAN-YU CHEN ; HAO-CHIEN WANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 10 | 8 | |